MedTrace Logo

Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary

NCT04669756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 409

Last updated 2021-04-28

No results posted yet for this study

Summary

prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after surgery because of endometriosis of the pelvic side wall or the ovary or both

Conditions

  • Endometriosis
  • Adhesion
  • Surgery

Interventions

PROCEDURE

ovariopexy

if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall

PROCEDURE

placebo operation

in arm D sutures are transabdominal only

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Sebastian D Schaefer, MD PhD · University Hospital Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2021-01-08
Completion
2021-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04669756 on ClinicalTrials.gov